介质细胞干细胞恶性转变的分子前景:细胞治疗中的问题
Maryam Kaviani1, Saeede Soleimanian1,2, Somayeh Keshtkar1,3
1Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Cellular reprogramming
|June 25, 2024
概括
介质细胞干细胞 (MSC) 治疗显示出有希望的结果,但存在风险. 本综述探讨了MSC恶性转变的潜在机制,以确保治疗安全.
科学领域:
- 生物医学科学 生物医学科学
- 再生医学是一种再生医学.
- 干细胞生物学 干细胞生物学
背景情况:
- 介酶干细胞 (MSC) 是具有再生和免疫调节特性的多能细胞.
- MSC治疗正在针对各种疾病进行研究,显示出显著的前景.
- 有关移植后MSCs恶性转变的可能性存在担忧.
研究的目的:
- 审查和总结MSC恶性转变的潜在机制.
- 强调了解这些机制对于基于MSC的安全疗法的重要性.
主要方法:
- 对调查MSC行为和转变的研究进行文献综述.
- 分析与MSC移植相关的实验模型和临床试验数据.
- 检查涉及瘤变化的拟议分子和细胞途径.
主要成果:
- 研究表明,在MSC移植后的实验模型中,血液恶性瘤和癌症发生可能增加.
- 恶性转化机制是复杂的,涉及信号分子和改变细胞调节.
- 关键的途径包括自发和受刺激的转化,细胞融合和瘤微环境.
结论:
- 了解MSC恶性转变对于MSC治疗的安全性和有效性至关重要.
- 进一步研究致癌途径是必要的,以减轻风险.
- 解决恶性瘤问题将促进MSC疗法的临床转化.
相关概念视频
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Stem Cell Culture
5.1K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.1K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K


